Key facts
- Gnosis Health’s last known valuation is $3.9M (Aug 2025).
- It has raised $430K; the latest was Later Stage VC ($430K) in Aug 2025.
- Notable investors include SFC Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Gnosis Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Gnosis Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gnosis Health
Developer of an AI-based healthtech platform designed to improve the management of chronic diseases. The company's platform utilizes a combination of patient-reported outcomes on symptoms, treatment effects, and daily challenges to analyze data and create actionable recommendations, enabling healthcare professionals to optimize care and make evidence-based decisions in a personalized manner.
- Sector
- Healthcare
- HQ
- Newcastle Upon Tyne, United Kingdom
- Founded
- 2018
- Employees
- 2
- Website
- gnosishealth.net/
- Ownership
- Privately Held (backing)
Gnosis Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gnosis Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gnosis Health in its N-PORT filings yet. We sweep new filings monthly.